Rna guided compositions for preventing and treating hepatitis b virus infections
AssigneeTemple University of the Commonwealth System of Higher Education
InventorsKamel Khalili, Hassen Wollebo
Life of this patent
Estimating the term…
Abstract
Compositions that specifically cleave target sequences in Hepadnaviridae, for example Hepatitis B virus (HBV) include nucleic acids encoding a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to a target sequence in HBV. These compositions are administered to a subject for eradicating an infection, latent or otherwise, or at risk for contracting HBV infection.
Claims19
A composition for eradicating a hepadnavirus in vitro or in vivo, the composition comprising:
- an isolated nucleic acid sequence encoding a Clustered Regularly interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease and at least one guide RNA (gRNA), the gRNA being complementary to a target nucleic acid sequence in a hepadnavirus genome.
(canceled)
(canceled)
(canceled)
A composition for eradicating a hepadnavirus in vitro or in vivo, the composition comprising:
- an isolated nucleic acid sequence encoding a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease and two or more guide RNAs (gRNAs), the gRNAs being complementary to a target nucleic acid sequence in a hepadnavirus genome.
(canceled)
(canceled)
An isolated nucleic acid sequence comprising at least a 50% sequence identity to one or more sequences comprising SEQ ID NOS:
- 1 to 30.
Dependencies are inferred from the claim text.